Motley Fool Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $4.12M | Buy |
|
|||||
|
2025
Q2 | $2.17M | Buy |
|
|||||
|
2025
Q1 | $1.63M | Buy |
|
|||||
|
2024
Q4 | $447K | Buy |
|
|||||
|
2024
Q3 | $486K | Sell |
|
|||||
|
2024
Q2 | $460K | Sell |
|
|||||
|
2024
Q1 | $293K | Sell |
|
|||||
|
2023
Q4 | $390K | Sell |
|
|||||
|
2023
Q3 | $395K | Sell |
|
|||||
|
2023
Q2 | $433K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $518K | Sell |
|
|||||
|
2022
Q3 | $476K | Sell |
|
|||||
|
2022
Q2 | $367K | Buy |
|
|||||
|
2022
Q1 | $396K | Buy |
|
|||||
|
2021
Q4 | $9K | Buy |
|